SNC116 / Shanghai Simnova Bio - LARVOL DELTA

SNC116 Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (clinicaltrials.gov) - P1 | N=28 | Not yet recruiting | Sponsor: Shanghai Simnova Biotechnology Co.,Ltd.

New P1 trial • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Oncology • CD19

SNC116 Therapy for Refractory Systemic Lupus Erythematosus (clinicaltrials.gov) - P1 | N=28 | Not yet recruiting | Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus